Companies · Healthtech

HealthPrize Technologies, LLC

NORWALK · Healthtech · refined from filed group “Other Technology

Diligence memoA one-page analyst read on HealthPrize Technologies, LLC — recommendation, valuation, rhythm, risks.
$14.4M
Total raised · real
7
Rounds
1.1×
Latest step-up
Top 26%
Sector rank · raised
Seed
Latest stage · inferred · Thu Oct 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

HealthPrize Technologies, LLC looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.81× the median modeled value of Seed Healthtech companies in 2019–2021 (180 peers) — value vs value, same stage and era.
Dormant
  • Last raise 6.7 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

HealthPrize Technologies, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
16.5 yr record
Peak capital year was 2014 with $6.0M across 2 filings.
Market position
ahead of 75% of Healthtech peers
Capital scale is ahead of 75% of Healthtech peers; modeled value is above 72% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2014: $6.0M across 2 filings.
  • Largest single filing was $3.0M on 2014-08-18.
  • Filing rows sum to $19.1M, while canonical raised total is $14.4M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

HealthPrize Technologies, LLC is one of 2138 Healthtech companies tracked from NORWALK. By capital raised it ranks in the upper tier (ahead of 75% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
20
Investors (latest)
2019-10-31
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MPre-Seed · 2010-01-12 Raised $150K (real) Modeled valuation $5.2M (est)Pre-Seed2010Seed · 2010-01-12 Raised $1.2M (real) Modeled valuation $33M (est)Seed2010Pre-Seed · 2010-01-12 Raised $350K (real) Modeled valuation $12M (est)Pre-Seed2010Seed · 2010-01-12 Raised $1.6M (real) Modeled valuation $44M (est)Seed2010Seed · 2012-01-20 Raised $2.0M (real) Modeled valuation $55M (est)Seed2012Seed · 2012-12-17 Raised $632K (real) Modeled valuation $18M (est)Seed2012Seed · 2013-11-14 Raised $1.3M (real) Modeled valuation $36M (est)Seed2013Seed · 2014-08-18 Raised $3.0M (real) Modeled valuation $83M (est)Seed2014Seed · 2014-08-18 Raised $3.0M (real) Modeled valuation $83M (est)Seed2014Seed · 2016-06-21 Raised $2.9M (real) Modeled valuation $79M (est)Seed2016Seed · 2019-10-31 Raised $3.0M (real) Modeled valuation $83M (est)Seed2019Cumulative $19M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$150K · 2010
Seed$1.2M · 2010
Bridge · Seed-stage$350K · 2010smaller follow-on
Seed extension$1.6M · 2010
Seed extension$2.0M · 2012
Seed extension$632K · 2012
Seed extension$1.3M · 2013
Seed extension$3.0M · 2014
Seed extension$3.0M · 2014
Seed extension$2.9M · 2016
Seed extension$3.0M · 2019

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$83.1M
Base estimate est.
$2.5M
Conservative case
$652.2M
Upside case
$15.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $5.2M · 2010-01-122010Seed · modeled $33.3M · 2010-01-12Pre-Seed · modeled $12.1M · 2010-01-12Seed · modeled $44.4M · 2010-01-12Seed · modeled $55.5M · 2012-01-20Seed · modeled $17.5M · 2012-12-17Seed · modeled $36.0M · 2013-11-14Seed · modeled $83.2M · 2014-08-18Seed · modeled $83.2M · 2014-08-18Seed · modeled $79.0M · 2016-06-21Seed · modeled $83.1M · 2019-10-312019
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.57×/yr
Annual markup
2.05×/yr upside case
6.0 yr
Elapsed time used
6.7 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
12 mo
Avg between rounds
$1.5M/yr
Capital velocity
16.5 yr
On record since
2010
First round
11
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 3.2× above median
This company$14.4M
Sector median$4.5M
Latest round — vs other Seed rounds in sector (real $, this stage) 1.6× above median
This company$3.0M
Sector median$1.9M
Modeled value — vs sector median (estimate, all stages) 2.5× above median
This company$83.1M
Sector median$33.8M

Raised more than 75% of sector peers (real $). Modeled value above 72% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #22 of 180.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Hippo Health, Inc. · Seed Raised $4.0M · modeled $110.9M (est)Primacy Health Inc. · Seed Raised $4.0M · modeled $110.9M (est)Ursa Major Natural Care, Inc. · Seed Raised $4.0M · modeled $110.9M (est)Able Health Inc. · Seed Raised $3.9M · modeled $107.5M (est)Gentem Health Inc · Seed Raised $3.8M · modeled $105.1M (est)Insight Medical Holdings, LLC · Seed Raised $3.8M · modeled $104.0M (est)Paragon Southwest Medical Waste, LLC · Seed Raised $6.7M · modeled $101.6M (est)Fresenius Medical Care Sloans Lake, LLC · Seed Raised $3.6M · modeled $99.2M (est)Karuna Health, Inc. · Seed Raised $4.7M · modeled $97.0M (est)Fresenius Medical Care Fairmount Heights, LLC · Seed Raised $3.4M · modeled $93.0M (est)WELL Health Technologies Corp. · Seed Raised $3.7M · modeled $92.8M (est)Fresenius Medical Care Rock Quarry, LLC · Seed Raised $3.3M · modeled $92.5M (est)HealthPrize Technologies, LLC (this company) Raised $14.4M · modeled $83.1M (est)HealthPrize Technologies, LLC
CompanyStageRaised · realValue · estvs peer med.
Hippo Health, Inc.Seed$4.0M$110.9M2.42×
Primacy Health Inc.Seed$4.0M$110.9M2.42×
Ursa Major Natural Care, Inc.Seed$4.0M$110.9M2.42×
Able Health Inc.Seed$3.9M$107.5M2.34×
Gentem Health IncSeed$3.8M$105.1M2.29×
Insight Medical Holdings, LLCSeed$3.8M$104.0M2.27×
Paragon Southwest Medical Waste, LLCSeed$6.7M$101.6M2.21×
Fresenius Medical Care Sloans Lake, LLCSeed$3.6M$99.2M2.16×
Karuna Health, Inc.Seed$4.7M$97.0M2.12×
Fresenius Medical Care Fairmount Heights, LLCSeed$3.4M$93.0M2.03×
WELL Health Technologies Corp.Seed$3.7M$92.8M2.02×
Fresenius Medical Care Rock Quarry, LLCSeed$3.3M$92.5M2.01×
HealthPrize Technologies, LLC this companySeed$14.4M$83.1M1.81×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$150K2010-01-12$833K$5.2M85%
Seed$1.2M2010-01-12$6.0M$33.3M85%
Pre-Seed$350K2010-01-12$1.9M$12.1M85%
Seed$1.6M2010-01-12$8.0M$44.4M85%
Seed$2.0M2012-01-20$10.0M$55.5M85%
Seed$632K2012-12-17$3.2M$17.5M85%
Seed$1.3M2013-11-14$6.5M$36.0M85%
Seed$3.0M2014-08-18$15.0M$83.2M85%
Seed$3.0M2014-08-18$15.0M$83.2M85%
Seed$2.9M2016-06-21$14.3M$79.0M85%
Seed$3.0M2019-10-31$15.0M$83.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$150K2010-01-12
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
  2. Seed$1.2M2010-01-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 8.0× larger than the prior — scaling up.
    • 8 investors on this round.
  3. Pre-Seed$350K2010-01-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.4× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  4. Seed$1.6M2010-01-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 4.6× larger than the prior — scaling up.
    • 8 investors on this round.
  5. Seed$2.0M2012-01-20
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • Revenue band moved No revenue → $0–$1M.
    • 7 investors on this round.
  6. Seed$632K2012-12-17
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 3.2× smaller than the prior — bridge or down round.
    • Revenue band moved $0–$1M → $1M–$5M.
    • 6 investors on this round.
  7. Seed$1.3M2013-11-14
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 2.1× larger than the prior — scaling up.
    • Revenue band moved $1M–$5M → $0–$1M.
    • Switched to Rule 506(b) (was Rule 06).
    • 6 investors on this round.
  8. Seed$3.0M2014-08-18
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round 2.3× larger than the prior — scaling up.
    • 2 investors on this round.
  9. Seed$3.0M2014-08-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • Revenue band moved $0–$1M → $1M–$5M.
    • 2 investors on this round.
  10. Seed$2.9M2016-06-21
    • Raised again after 22 mo — slower than the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 13 investors on this round.
  11. Seed$3.0M2019-10-31
    • Raised again after 40 mo — slower than the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 20 investors on this round.
Intelligence
2020 ~Q4
Modeled next raise · ~12mo cadence
$3.2M
Modeled next size est.range $3.0M$5.0M
1.1×
Last step-up
$1.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Rector10 other2016-06
Kevin Jones5 other2010-01
Dawn Owens3 other2016-06
Dieter Weinand3 other2016-06
Robert Dahl3 other2019-10
MICHAEL A. GRIFFITH2 other2019-10
Robert Kamerschen2 other2010-01
Douglas Poling1 other2012-01
Mark DiSalvo1 other2019-10
Douglas A Poling2019-10
Hensley Evans2019-10
James Jorasch2010-01
John A Monahan2019-10
Katrina Firlik2010-01
Ruben King-Shaw Jr.2014-08
Thomas Kottler2010-01
Registry & provenance

HealthPrize Technologies, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1484768
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Novo Health Inc.HealthtechSeed$2.1M$43.5Mnetwork1 shared operator · same sector · same stage
Wildflower Health, Inc.HealthtechSeries B$19.6M$106.7Mnetwork1 shared operator · same sector
Cecelia Health, Inc.HealthtechSeed$11.8M$71.1Msame sector · same stage
Q Care International LlcHealthtechSeed$10.7M$106.8Msame sector · same stage
Pyx Health Holdings, LlcHealthtechSeries B$28.1M$260.8Mnetwork1 shared operator · same sector
Titan Medical IncHealthtechSeed$10.0M$63.0Msame sector · same stage
Lucina Health, Inc.HealthtechSeed$24.0M$50.1Msame sector · same stage
Broad Axe Care Coordination LlcHealthtechSeed$8.4M$61.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Sopris Health, Inc.HealthtechSeed$95.4M89%
Healthe, Inc.HealthtechSeries B$465.2M89%
Better Health Technologies Inc.HealthtechSeries A$211.9M88%
Healthcare, Inc.HealthtechSeries D+$4.0B88%
Healthfinch, Inc.HealthtechSeries A$129.6M88%
HealthReveal, Inc.HealthtechSeries B$659.2M88%
Medaptive Health, Inc.HealthtechSeed$34.0M87%
Health & Technologies IncHealthtechPre-Seed$7.5M87%
Frequently asked
How much funding has HealthPrize Technologies, LLC raised?
HealthPrize Technologies, LLC has raised approximately $14.4M in disclosed capital across 7 recorded financing rounds, aggregated from public filings.
What is HealthPrize Technologies, LLC's estimated valuation?
Provath's modeled valuation for HealthPrize Technologies, LLC is approximately $83.1M (modeled range $2.5M–$652.2M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is HealthPrize Technologies, LLC at?
HealthPrize Technologies, LLC's latest modeled financing stage is Seed. Its most recent recorded round closed around Thu Oct 31.
What does HealthPrize Technologies, LLC do and where is it based?
HealthPrize Technologies, LLC operates in the Healthtech sector, based in NORWALK.
Explore related

See where HealthPrize Technologies, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at HealthPrize Technologies, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.